Epsilon M&A Deal Report - Xelect
Transaction Multiples for the Valuation of Private Companies
Genus / Xelect
No EMAT :
116141
Announced Date :
02/03/2021
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Genus
Target :
Xelect
Country :
Scotland
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
Business Description :
Xelect is a provider of specialist genetics and breeding management services to the aquaculture industry. > Manages and supports breeding programmes on behalf of leading producers of farmed finfish...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
- Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 28/06/2021 | Genus | Sergal Gestió Ramadera | Spain | *** | 116109 |
| 23/02/2017 | Genus | Hermitage Genetics Designated Activity Company | Ireland | ** | 116100 |
Source: Epsilon Research / EMAT
